SYK and cancer: In hematopoietic malignancies, the non-receptor spleen tyrosine kinase (SYK) mainly contributes to cancer cell survival and proliferation [3,4,5] by mediating tonic and chronic signaling through B-cell antigen receptors in different B-cell-derived lymphoma types [6,7,8].